Related Experiment Video
Updated: Jan 1, 2026

08:30
Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells
Published on: January 7, 2020
13.8K
Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference.
Yuanhua Huang1,2, Davis J McCarthy3,4,5, Oliver Stegle6,7,8
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK. yuanhua@ebi.ac.uk.
Genome Biology
|December 15, 2019
Summary
Vireo is a new Bayesian model that efficiently demultiplexes single-cell RNA sequencing data from pooled samples. It works even without complete genetic information, making multiplexed experiments more accessible.
Area of Science:
- Genomics
- Computational Biology
- Molecular Biology
Background:
- Multiplexed single-cell RNA sequencing (scRNA-seq) enables higher throughput and batch effect correction.
- Demultiplexing cells to their original samples typically requires complete genotype data, limiting its application.
- Existing methods are constrained by the need for comprehensive genetic information.
Purpose of the Study:
- To introduce Vireo, a computationally efficient Bayesian model for demultiplexing scRNA-seq data from pooled samples.
- To enable demultiplexing even with partial or no prior genotype information.
- To broaden the applicability of multiplexed scRNA-seq experimental designs.
Main Methods:
- Development of a Bayesian model named Vireo.
- Application of Vireo to synthetic mixtures and real scRNA-seq data.
- Utilizing genetic variants as natural barcodes for cell demultiplexing.
Main Results:
- Vireo demonstrates robust performance in demultiplexing pooled scRNA-seq data.
- The model successfully demultiplexes cells without requiring complete genotype information.
- Validation using both synthetic and real experimental datasets.
Conclusions:
- Vireo enhances the utility of multiplexed scRNA-seq designs by overcoming genotype data limitations.
- The method provides a flexible and efficient approach for cell demultiplexing.
- Facilitates broader adoption of pooled scRNA-seq for various expression analyses.

